Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma

We have shown that the proteasome inhibitor bortezomib (formerly known as PS-341) triggers significant antitumor activity in multiple myeloma (MM) in both preclinical models and patients with relapsed refractory disease. Recent studies have shown that unfolded and misfolded ubiquitinated proteins ar...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hideshima, Teru, Bradner, James E., Wong, Jason, Chauhan, Dharminder, Richardson, Paul, Schreiber, Stuart L., Anderson, Kenneth C.
Médium: Artigo
Jazyk:Inglês
Vydáno: National Academy of Sciences 2005
Témata:
Biological Sciences
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1150844/
https://ncbi.nlm.nih.gov/pubmed/15937109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0503221102
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky